Eva Guerra
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
-
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 12
- PARP inhibition in cancer therapy 7
- Cancer Immunotherapy and Biomarkers 3
- Cancer Treatment and Pharmacology 2
-
- Ovarian cancer diagnosis and treatment 12
- Co-authors
- Ignacio Romero (8 shared papers)Emilio Álvarez-Cuesta (1 shared paper)Ricardo Madrigal‐Burgaleta (1 shared paper)Antonio González-Martı́n (6 shared papers)María Pilar Berges‐Gimeno (1 shared paper)Andrés Poveda (6 shared papers)Bradley J. Monk (3 shared papers)Ignace Vergote (4 shared papers)
In The Last Decade
Eva Guerra
22 papers receiving 151 citations
Peers
Comparison fields: 5 of 36
- Reproductive Medicine 61
- Oncology 78
- Obstetrics and Gynecology 20
- Toxicology 5
- Immunology 26
Countries citing papers authored by Eva Guerra
This map shows the geographic impact of Eva Guerra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Guerra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Guerra more than expected).
Fields of papers citing papers by Eva Guerra
This network shows the impact of papers produced by Eva Guerra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Guerra. The network helps show where Eva Guerra may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Guerra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 19 | |
| 2 | 2017 | 19 | |
| 3 | 2020 | 16 | |
| 4 | 2023 | 15 | |
| 5 | 2012 | 12 | |
| 6 | 2019 | 9 | |
| 7 | 2022 | 9 | |
| 8 | 2023 | 7 | |
| 9 | 2020 | 7 | |
| 10 | 2021 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 6 | |
| 13 | 2017 | 5 | |
| 14 | 2014 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 1 |
About Eva Guerra
Eva Guerra is a scholar working on Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Cancer Research, having authored 23 papers that have together received 153 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (12 papers), PARP inhibition in cancer therapy (7 papers), Endometrial and Cervical Cancer Treatments (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Genomics and Diagnostics (2 papers), BRCA gene mutations in cancer (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Reproductive Medicine (61 citations), Oncology (78 citations), Obstetrics and Gynecology (20 citations), Toxicology (5 citations) and Immunology (26 citations). Eva Guerra has collaborated with scholars based in Spain, Italy and Belgium. Frequent co-authors include Ignacio Romero, Emilio Álvarez-Cuesta, Ricardo Madrigal‐Burgaleta, Antonio González-Martı́n, María Pilar Berges‐Gimeno, Andrés Poveda, Bradley J. Monk, Ignace Vergote, María Jesús Rubio and Ana Oaknin. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Gynecological Cancer, Cancers, Frontiers in Oncology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.